Sarepta Therapeutics (SRPT) Financials: Revenue & Earnings

SRPT price $19.09 +0.20 +1.03%

Ticker
SRPT
Price
$19.09
Change
+0.20 +1.03%
Market cap ?
$2.02B
P/E ?
-12.31
Forward P/E ?
6.19
Dividend yield ?
0.00%
Beta ?
0.20
Sector
Healthcare
Industry
Biotechnology

Financials

2016201720182019202020212022202320242025
5421000154584000301034000380833000540099000701887000933013000124333600019019790002198237000

Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company dedicated to the discovery and advancement of genetic treatment modalities, including RNA-targeted therapeutics and gene therapies, specifically for rare diseases. The company currently offers two approved treatments: EXONDYS 51, prescribed for Duchenne muscular dystrophy (DMD) patients with confirmed dystrophin gene mutations amenable to…

Fair value

SRPT fair value $5.71. Price $19.09. Price is 234% above fair value.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.

Model uncertainty high for this stock

Compare SRPT

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2026-11-05—0.07—352.20M
2026-08-05-0.050.22401.25M366.39M
2026-05-063.160.98730.80M474.16M
2026-02-25-3.58-1.03442.93M369.60M
2025-11-03-1.80-0.73399.36M335.76M
2025-08-062.020.83611.09M530.66M
2025-05-06-4.60-0.87744.86M687.47M
2025-02-261.501.38658.41M631.03M
2024-11-060.34-0.06467.17M407.17M
2024-08-070.070.01362.93M394.38M
2024-05-010.370.01413.46M379.52M
2024-02-280.470.01396.78M385.81M
2023-11-01-0.46-1.66331.82M363.15M
2023-08-02-0.27-1.89261.24M259.55M
2023-05-02-5.86-1.38253.50M241.92M
2023-02-28-1.24-1.28258.43M250.40M
2022-11-02-2.94-1.21230.27M234.52M
2022-08-02-2.65-1.07233.49M220.81M
2022-05-04-1.20-1.35210.83M206.43M
2022-03-01-1.42-1.51201.46M197.97M
2021-11-03-0.60-1.86189.41M285.94M
2021-08-04-1.02-1.03164.09M162.65M
2021-05-05-2.10-2.01146.93M149.16M
2021-03-01-2.40-2.00145.14M146.29M
2020-11-05-2.50-1.89143.92M98.44M
2020-08-05-1.93-1.81137.36M125.26M
2020-05-06-0.23-2.29113.67M192.10M
2020-02-26-3.16-1.83100.11M74.60M
2019-11-07-1.70-1.3499.04M78.65M
2019-08-07-3.74-1.0894.67M34.68M
2019-05-08-1.07-2.0587.01M138.24M
2019-02-27-0.85-0.6684.42M78.74M
2018-10-24-0.56-0.3478.49M55.28M
2018-08-08-0.43-0.4773.53M50.61M
2018-05-03-0.28-0.3264.60M44.97M
2018-03-01-0.37-0.3157.28M49.54M
2017-10-25-0.78-0.8645.95M50.07M
2017-07-19-1.15-0.9235.01M27.70M
2017-04-27-0.73-0.8516.34M3.49M
2017-02-28-1.58-1.265.42M8.29M

Dividends

Yield 0.00%. Payout ratio 0.00%. Frequency —.

Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.

Ex-dateDividendRecordPaymentFrequency
No data yet.

Insider trades

DateInsiderActionSharesPriceValue
2026-09-04Wong Ryan Ho-YanSell13.27K$22.22294.90K
2026-09-04Estepan Ian MichaelSell24.80K$22.22551.03K
2026-09-04Rothfuss CristinSell22.02K$22.22489.40K
2026-09-04Rodino-Klapac LouiseSell21.42K$22.22476.02K
2026-07-28SEVERINO MICHAELBuy2.22M$17.7439.46M
2026-07-28SEVERINO MICHAELBuy756.10K——
2026-07-28SEVERINO MICHAELOther0——
2026-06-04Boor Kathryn JeanBuy16.88K——
2026-06-04Mayo StephenBuy16.88K——
2026-06-04Wigzell Hans Lennart RudolfBuy16.88K——
2026-06-04BEHRENS M KATHLEENBuy16.88K——
2026-06-04Connelly Deirdre PBuy16.88K——
2026-06-04Nicaise ClaudeBuy16.88K——
2026-06-04Chambers Michael AndrewBuy16.88K——
2026-06-04Barry RichardBuy16.88K——
2026-03-12Mayo StephenSell7.24K$17.02123.21K
2026-03-11Estepan Ian MichaelSell1.10K$17.0318.68K
2026-03-11Wong Ryan Ho-YanSell256$17.034.36K
2026-03-11Rodino-Klapac LouiseSell948$17.0316.14K
2026-03-11Rothfuss CristinSell974$17.0316.59K
2026-03-10Wong Ryan Ho-YanOther1.21K$99.69120.43K
2026-03-09Wong Ryan Ho-YanSell162$16.952.75K
2026-03-09Wong Ryan Ho-YanSell113$16.951.92K
2026-03-09Rothfuss CristinSell484$16.958.20K
2026-03-09Rothfuss CristinSell346$16.955.86K
2026-03-09Rodino-Klapac LouiseSell504$16.958.54K
2026-03-09Rodino-Klapac LouiseSell895$16.9515.17K
2026-03-09Estepan Ian MichaelSell1.04K$16.9517.56K
2026-03-09Estepan Ian MichaelSell583$16.959.88K
2026-03-02Rothfuss CristinSell408$16.206.61K
2026-03-02Wong Ryan Ho-YanSell450$16.207.29K
2026-03-02Estepan Ian MichaelSell3.30K$16.2053.48K
2026-03-02Estepan Ian MichaelSell875$16.2014.18K
2026-03-02Rodino-Klapac LouiseSell3.72K$16.2060.23K
2026-03-02Rodino-Klapac LouiseSell767$16.2012.43K
2026-03-01Estepan Ian MichaelBuy8.12K——
2026-03-01Estepan Ian MichaelSell8.12K——
2026-03-01Rodino-Klapac LouiseBuy8.12K——
2026-03-01Rodino-Klapac LouiseSell8.12K——
2026-02-26Estepan Ian MichaelBuy5.38K$13.7173.77K
2026-02-26Estepan Ian MichaelBuy2.07K$13.7128.37K
2026-02-26Estepan Ian MichaelSell5.38K$13.7173.77K
2026-02-25Estepan Ian MichaelBuy1.88K——
2026-02-25Rodino-Klapac LouiseBuy1.88K——
2026-01-29Nicaise ClaudeBuy10.50K$13.71143.96K
2026-01-29Nicaise ClaudeSell6.78K$21.23143.94K
2026-01-29Nicaise ClaudeSell10.50K$13.71143.96K
2026-01-27BEHRENS M KATHLEENBuy10.50K$13.71143.96K
2026-01-27BEHRENS M KATHLEENSell6.49K$22.17143.97K
2026-01-27BEHRENS M KATHLEENBuy10.50K$13.71143.96K
2025-12-18Chambers Michael AndrewSell0$141.970
2025-12-18Chambers Michael AndrewBuy0$60.000
2025-12-16Estepan Ian MichaelSell13.19K$22.31294.20K
2025-12-07INGRAM DOUGLAS SBuy269.54K——
2025-12-07INGRAM DOUGLAS SBuy96.54K——
2025-12-07INGRAM DOUGLAS SBuy73.00K——
2025-12-07INGRAM DOUGLAS SBuy50.00K——
2025-12-07INGRAM DOUGLAS SBuy50.00K——
2025-12-01Wong Ryan Ho-YanSell80$20.961.68K
2025-12-01Wong Ryan Ho-YanSell78$20.961.63K
2025-11-28Rothfuss CristinSell229$21.124.84K
2025-11-17Rodino-Klapac LouiseSell4.58K$18.4284.40K
2025-09-03Rodino-Klapac LouiseBuy50.00K——
2025-09-03Rodino-Klapac LouiseBuy93.88K——
2025-09-03Wong Ryan Ho-YanBuy25.00K——
2025-09-03Wong Ryan Ho-YanBuy93.88K——
2025-09-03Estepan Ian MichaelBuy50.00K——
2025-09-03Estepan Ian MichaelBuy93.88K——
2025-09-03Rothfuss CristinBuy25.00K——
2025-09-03Rothfuss CristinBuy93.88K——
2025-08-05Arif BilalBuy6.25K——
2025-08-05Estepan Ian MichaelBuy6.25K——
2025-08-05Rodino-Klapac LouiseBuy6.25K——
2025-07-31Wong Ryan Ho-YanSell327$16.425.37K
2025-07-16Wong Ryan Ho-YanOther0——
2025-05-16Barry RichardBuy12.35K$32.63402.98K
2025-05-16Barry RichardSell12.35K$32.63402.98K
2025-05-13Barry RichardBuy10.50K$13.71143.96K
2025-05-13Barry RichardBuy9.75K$25.18245.40K
2025-05-13Barry RichardSell10.50K$13.71143.96K
2025-05-13Barry RichardSell9.75K$25.18245.40K
2025-03-12Nicaise ClaudeBuy9.75K$25.18245.40K
2025-03-12Nicaise ClaudeSell2.49K$99.64248.20K
2025-03-12Nicaise ClaudeSell9.75K$25.18245.40K
2025-03-10Connelly Deirdre PBuy2.38K——
2025-03-10Connelly Deirdre PBuy4.79K$99.69477.71K
2025-03-10Boor Kathryn JeanBuy2.38K——
2025-03-10Boor Kathryn JeanBuy4.79K$99.69477.71K
2025-03-10Chambers Michael AndrewBuy2.38K——
2025-03-10Chambers Michael AndrewBuy4.79K$99.69477.71K
2025-03-10Estepan Ian MichaelBuy8.28K——
2025-03-10Estepan Ian MichaelSell1.05K$100.13105.24K
2025-03-10Estepan Ian MichaelSell2.89K$100.13289.38K
2025-03-10Rothfuss CristinBuy8.28K——
2025-03-10Estepan Ian MichaelBuy16.64K$99.691.66M
2025-03-10Rothfuss CristinBuy16.64K$99.691.66M
2025-03-10Rothfuss CristinSell491$100.1349.16K
2025-03-10Wigzell Hans Lennart RudolfBuy2.38K——
2025-03-10Wigzell Hans Lennart RudolfBuy4.79K$99.69477.71K
2025-03-10Mayo StephenBuy2.38K——

Institutional holders

Latest filed quarter: Q2 2026.

Institutions holding: 349, holders -25 vs prior quarter. Ownership 103.01%.

HolderSharesChangeChange %Value
BLACKROCK, INC.18.99M4.24M+28.73%341.34M
STATE STREET CORP8.92M2.30M+34.82%160.22M
VANGUARD PORTFOLIO MANAGEMENT LLC8.38M1.74M+26.15%150.54M
TWO SIGMA INVESTMENTS, LP4.60M5.54K+0.12%82.64M
VANGUARD CAPITAL MANAGEMENT LLC4.59M13.52K+0.30%82.51M
FIRST TRUST ADVISORS LP4.37M230.16K+5.57%78.46M
AQR CAPITAL MANAGEMENT LLC4.33M-2.11M-32.76%76.87M
GEODE CAPITAL MANAGEMENT, LLC2.77M782.96K+39.37%49.82M
ERSTE ASSET MANAGEMENT GMBH2.57M-400.00K-13.47%45.51M
MARSHALL WACE, LLP2.21M1.48M+204.25%39.64M
MORGAN STANLEY2.20M-394.35K-15.18%39.58M
ABERDEEN GROUP PLC2.19M-123.94K-5.34%39.44M
BANK OF AMERICA CORP /DE/2.06M-89.94K-4.19%36.95M
GOLDMAN SACHS GROUP INC2.04M964.25K+89.43%36.70M
UBS GROUP AG1.62M-608.04K-27.24%29.19M
FEDERATED HERMES, INC.1.59M-195.69K-10.96%28.58M
LMR PARTNERS LLP1.39M1.24M+797.16%25.02M
CITADEL ADVISORS LLC1.32M995.80K+306.78%23.73M
NORTHERN TRUST CORP1.21M486.47K+67.17%21.76M
MILLENNIUM MANAGEMENT LLC1.19M-28.21K-2.31%21.45M
T. ROWE PRICE INVESTMENT MANAGEMENT, INC.1.16M22.77K+2.01%20.77M
CITIGROUP INC1.16M7.36K+0.64%20.76M
RENAISSANCE TECHNOLOGIES LLC1.12M-543.70K-32.65%20.15M
CHARLES SCHWAB INVESTMENT MANAGEMENT INC980.32K189.19K+23.91%17.62M
SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P.980.32K980.32KNew17.62M

Earnings and financials

Sarepta Therapeutics, Inc. (SRPT) trades at $19.09, with a market cap of $2.02B and a trailing P/E of -12.31. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.

Financials

2016201720182019202020212022202320242025
5421000154584000301034000380833000540099000701887000933013000124333600019019790002198237000

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener

Sarepta Therapeutics (SRPT) Financials: Revenue & Earnings

SRPT$19.09+0.20 +1.03%

$2.02B

Market Cap

-12.31

P/E

6.19

Forward P/E

—

Score

Price History